USDA Grants Expanded Approval for Elanco's Canine Parvovirus Monoclonal Antibody, Enhancing Preventative Measures for Puppies Across the Nation

Reuters

Jun 27

USDA Grants Expanded Approval for Elanco's Canine Parvovirus Monoclonal Antibody, Enhancing Preventative Measures for Puppies Across the Nation

Elanco Animal Health Inc. has announced a significant regulatory milestone with the U.S. Department of Agriculture (USDA) granting expanded approval for its Canine Parvovirus Monoclonal Antibody (CPMA). This approval allows the use of CPMA for passive immunity, providing veterinarians with a preventative option to protect puppies exposed to the deadly canine parvovirus. In line with their mission "Defend Puppies. Defeat Parvo.", Elanco has also donated over $3 million worth of CPMA to 2,300 clinics and shelters in high parvo risk areas, broadening access to this life-saving treatment. This initiative has already seen success, with the largest recorded group of 27 parvo-infected puppies saved at the SPCA of Brevard Adoption Center in Florida.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Elanco Animal Health Inc. published the original content used to generate this news brief on June 27, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/2546094749"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2546094749\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2546094749?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-06-27 21:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2546094749","market":"nz","top_or_hot":-1,"title":"USDA Grants Expanded Approval for Elanco's Canine Parvovirus Monoclonal Antibody, Enhancing Preventative Measures for Puppies Across the Nation","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      USDA Grants Expanded Approval for Elanco's Canine Parvovirus Monoclonal Antibody, Enhancing Preventative Measures for Puppies Across the Nation\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        <a href=\"https://laohu8.com/S/ELAN\">Elanco Animal Health Inc</a>. has announced a significant regulatory milestone with the U.S. Department of Agriculture (USDA) granting expanded approval for its Canine Parvovirus Monoclonal Antibody (CPMA). This approval allows the use of CPMA for passive immunity, providing veterinarians with a preventative option to protect puppies exposed to the deadly canine parvovirus. In line with their mission \"Defend Puppies. Defeat Parvo.\", Elanco has also donated over $3 million worth of CPMA to 2,300 clinics and shelters in high parvo risk areas, broadening access to this life-saving treatment. This initiative has already seen success, with the largest recorded group of 27 parvo-infected puppies saved at the SPCA of Brevard Adoption Center in Florida.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Elanco Animal Health Inc. published the original content used to generate this news brief on June 27, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>USDA Grants Expanded Approval for Elanco's Canine Parvovirus Monoclonal Antibody, Enhancing Preventative Measures for Puppies Across the Nation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUSDA Grants Expanded Approval for Elanco's Canine Parvovirus Monoclonal Antibody, Enhancing Preventative Measures for Puppies Across the Nation\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-06-27 21:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      USDA Grants Expanded Approval for Elanco's Canine Parvovirus Monoclonal Antibody, Enhancing Preventative Measures for Puppies Across the Nation\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        <a href=\"https://laohu8.com/S/ELAN\">Elanco Animal Health Inc</a>. has announced a significant regulatory milestone with the U.S. Department of Agriculture (USDA) granting expanded approval for its Canine Parvovirus Monoclonal Antibody (CPMA). This approval allows the use of CPMA for passive immunity, providing veterinarians with a preventative option to protect puppies exposed to the deadly canine parvovirus. In line with their mission \"Defend Puppies. Defeat Parvo.\", Elanco has also donated over $3 million worth of CPMA to 2,300 clinics and shelters in high parvo risk areas, broadening access to this life-saving treatment. This initiative has already seen success, with the largest recorded group of 27 parvo-infected puppies saved at the SPCA of Brevard Adoption Center in Florida.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Elanco Animal Health Inc. published the original content used to generate this news brief on June 27, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250627:nNDL9NKfSB:1","article_id":"2546094749","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2546094749","pubTimestamp":1751031744,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"USDA Grants Expanded Approval for Elanco's Canine Parvovirus Monoclonal Antibody, Enhancing Preventative Measures for Puppies Across the Nation. Elanco Animal Health Inc. has announced a significant regulatory milestone with the U.S. Department of Agriculture  granting expanded approval for its Canine Parvovirus Monoclonal Antibody . This approval allows the use of CPMA for passive immunity, providing veterinarians with a preventative option to protect puppies exposed to the deadly canine parvovirus. In line with their mission \"Defend Puppies. Defeat Parvo.\", Elanco has also donated over $3 million worth of CPMA to 2,300 clinics and shelters in high parvo risk areas, broadening access to this life-saving treatment. This initiative has already seen success, with the largest recorded group of 27 parvo-infected puppies saved at the SPCA of Brevard Adoption Center in Florida.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4007":"制药","ELAN":"Elanco Animal Health Inc","BK4561":"索罗斯持仓"},"translate_title":"美国农业部扩大对Elanco犬细小病毒单克隆抗体的批准，加强全国幼犬的预防措施","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ELAN":0.9},"content_text":"USDA Grants Expanded Approval for Elanco's Canine Parvovirus Monoclonal Antibody, Enhancing Preventative Measures for Puppies Across the Nation\n    \n\nElanco Animal Health Inc. has announced a significant regulatory milestone with the U.S. Department of Agriculture (USDA) granting expanded approval for its Canine Parvovirus Monoclonal Antibody (CPMA). This approval allows the use of CPMA for passive immunity, providing veterinarians with a preventative option to protect puppies exposed to the deadly canine parvovirus. In line with their mission \"Defend Puppies. Defeat Parvo.\", Elanco has also donated over $3 million worth of CPMA to 2,300 clinics and shelters in high parvo risk areas, broadening access to this life-saving treatment. This initiative has already seen success, with the largest recorded group of 27 parvo-infected puppies saved at the SPCA of Brevard Adoption Center in Florida.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Elanco Animal Health Inc. published the original content used to generate this news brief on June 27, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}